IQVIA Holdings Inc
IQV
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
73 / 240
Position in country
4681 / 14179
Return on Assets, %
5.2
-2.7
Net income margin, %
12.1
-6.7
EBITDA margin, %
21.5
5.6
Debt to Equity, %
223.7
15.1
Intangible assets and goodwill, %
72.7
4.7
Revenue CAGR 3Y, %
9.6
12.8
Total Equity change 1Y, %
6
-2.4
Revenue Y, % chg
3.9
0
P/E
32
32.1
P/BV
6.9
2
P/S
2.8
4.1
EV/S
3.6
3.6
EV/EBITDA
17.2
7.8
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
18.2
48.9
Forward P/E
20.3
25.5
Expected dividend per share
0
0
Payout Ratio, %
0
10.1
Competitors
Ranks
-
IQVIA Holdings Inc
00%
-
West Pharmaceutical Services Inc
00%
-
Agilent Technologies Inc
00%
-
Avantor Inc
00%
-
Thermo Fisher Scientific Inc
00%
-
Danaher Corp
00%
-
Waters Corp
00%
-
Mettler-Toledo International Inc
00%
-
Revvity Inc
00%
-
Illumina Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
United States of America
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Life Sciences Tools & Services
Sub-sector
Health Care
Capitalization (millions of $)
42512.7
Ticker
IQV.N
ISIN
US46266C1053
IPO date
2013-05-09
Availability on Russian exchanges
Yes
Reporting for
2024-02-15
Date fact. publication of reports
2023-12-31
Company Description
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: